Alpa Labs - Alpa Laboratories Share Price

88.171.91 (2.22%)
Volume: 63,206

Live
Last Updated On: 04 Jul, 2024, 02:07 PM IST

STOCK SCORE

ETPrime Only

TECHNICALS
COMPARE

Alpa Labs - Alpa Labora...

88.171.91 (2.22%)
Volume: 63,206

Overview
News
Analysis
Recos
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About
More
- MF
- F&O
- Corp Actions
- About
EnglishEnglishहिन्दी ગુજરાતી मराठी বাংলা ಕನ್ನಡ தமிழ்తెలుగు

Alpa Labs share price insights

View All

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 20.82% outperformed its 3 year CAGR of 6.57%. (Source: Consolidated Financials)
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 39.47% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 12.22% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
Stock Returns vs Nifty Pharma
Stock generated 39.47% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)
Alpa Labs Share Price Update
Alpa Laboratories Ltd. share price moved up by 2.22% from its previous close of Rs 86.26. Alpa Laboratories Ltd. stock last traded price is 88.17
Share Price Value
Today/Current/Last 88.1787.90
Previous Day 86.2686.38

Share Price	Value
Today/Current/Last	88.1787.90
Previous Day	86.2686.38

InsightsAlpa Labs

Do you find these insights useful?

hate it
meh
love it

Key Metrics

PE Ratio

(x)

10.97

EPS - TTM

(₹)

8.02

MCap

(₹ Cr.)

187.26

Sectoral MCap Rank

PB Ratio

(x)

1.19

Div Yield

(%)

0.00

Face Value

(₹)

10.00

Beta

-0.23

VWAP

(₹)

88.75

52W H/L

(₹)

115.00 / 68.10

Alpa Labs Share Price Returns

1 Day	2.22%
1 Week	4.16%
1 Month	18.19%
3 Months	-6.99%
1 Year	25.15%
3 Years	64.19%
5 Years	360.42%

ET Stock ScreenersTop Score Companies

Check whether Alpa Labs belongs to analysts' top-rated companies list?

View Stock Screeners

Alpa Labs News & Analysis

View all Alpa Labs Share News & Announcements

Alpa Labs Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

View Stock Score on a 10-point scale
See ratings on Earning, Fundamentals, Valuation, Risk & Price
Check stock performance

JOIN ET PRIME

Alpa Labs Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Alpa Labs Financials

Income (P&L)
Balance Sheet
Cash Flow
Ratios

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 20.82% outperformed its 3 year CAGR of 6.57%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 12.22% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

Quarterly \| Annual	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Total Income	27.57	30.84	35.35	29.87	28.47
Total Income Growth (%)	-10.60	-12.75	18.34	4.90	-5.04
Total Expenses	20.61	25.52	29.53	26.82	20.48
Total Expenses Growth (%)	-19.25	-13.59	10.13	30.96	-17.40
EBIT	6.97	5.32	5.81	3.05	8.00
EBIT Growth (%)	30.91	-8.47	90.59	-61.85	53.97
Profit after Tax (PAT)	3.55	4.51	5.79	3.03	4.65
PAT Growth (%)	-21.21	-22.11	90.88	-34.78	-9.15
EBIT Margin (%)	25.26	17.25	16.45	10.21	28.08
Net Profit Margin (%)	12.89	14.62	16.38	10.15	16.33
Basic EPS (₹)	1.71	2.17	2.75	1.44	2.12

Quarterly \| Annual	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Total Income	27.56	30.84	35.35	29.87	28.40
Total Income Growth (%)	-10.65	-12.75	18.34	5.16	-5.35
Total Expenses	20.60	25.49	29.57	26.83	20.44
Total Expenses Growth (%)	-19.20	-13.80	10.24	31.27	-17.57
EBIT	6.96	5.35	5.78	3.04	7.97
EBIT Growth (%)	30.10	-7.37	89.74	-61.80	52.73
Profit after Tax (PAT)	3.55	4.53	5.74	3.03	4.62
PAT Growth (%)	-21.71	-21.07	89.61	-34.54	-10.10
EBIT Margin (%)	25.26	17.34	16.34	10.19	28.05
Net Profit Margin (%)	12.87	14.69	16.24	10.13	16.28
Basic EPS (₹)	1.70	2.15	2.75	1.44	2.09

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	123.63	102.32	123.04	101.95	88.88
Total Revenue Growth (%)	20.82	-16.84	20.69	14.70	6.72
Total Expenses	102.95	86.43	103.48	91.16	85.97
Total Expenses Growth (%)	19.11	-16.47	13.51	6.04	6.47
Profit after Tax (PAT)	16.78	12.58	14.09	7.25	1.85
PAT Growth (%)	33.33	-10.71	94.45	291.01	133.46
Operating Profit Margin (%)	19.35	17.33	17.61	11.13	3.61
Net Profit Margin (%)	15.42	13.53	12.55	7.42	2.15
Basic EPS (₹)	8.01	5.88	6.70	3.44	0.88

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	123.61	102.36	123.06	101.96	88.94
Total Revenue Growth (%)	20.76	-16.82	20.69	14.65	7.08
Total Expenses	102.94	86.43	103.48	91.17	83.86
Total Expenses Growth (%)	19.10	-16.47	13.50	8.72	6.62
Profit after Tax (PAT)	16.78	12.62	14.13	7.26	4.08
PAT Growth (%)	32.90	-10.63	94.45	78.13	49.30
Operating Profit Margin (%)	19.37	17.37	17.65	11.16	6.13
Net Profit Margin (%)	15.42	13.58	12.58	7.44	4.74
Basic EPS (₹)	8.01	5.90	6.71	3.46	1.95

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	182.62	167.27	155.24	140.37	121.35
Total Assets Growth (%)	9.18	7.75	10.59	15.67	0.30
Total Liabilities	30.71	32.69	33.51	32.73	20.98
Total Liabilities Growth (%)	-6.06	-2.43	2.39	56.00	-7.63
Total Equity	151.91	134.58	121.73	107.64	100.37
Total Equity Growth (%)	12.88	10.55	13.09	7.24	2.13
Current Ratio (x)	5.69	4.67	4.43	3.73	4.59
Total Debt to Equity (x)	0.03	0.02	0.05	0.00	0.00
Contingent Liabilities	0.00	3.25	5.28	5.28	5.75

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	192.67	177.50	165.14	150.23	131.20
Total Assets Growth (%)	8.55	7.48	9.92	14.50	2.02
Total Liabilities	30.70	32.98	33.50	32.71	20.97
Total Liabilities Growth (%)	-6.91	-1.55	2.42	55.98	-7.58
Total Equity	161.97	144.53	131.64	117.52	110.23
Total Equity Growth (%)	12.07	9.79	12.01	6.61	4.08
Current Ratio (x)	5.65	4.95	4.78	3.69	4.54
Total Debt to Equity (x)	0.03	0.02	0.04	0.00	0.00
Contingent Liabilities	0.00	3.25	5.28	5.28	5.75

All figures in Rs Cr, unless mentioned otherwise

View Details

Insights

Cash from Operations vs PAT
Operating cash flow of Rs 3.65 cr is 0.22 times compared to the reported net profit of Rs 16.78 cr. (Source: Consolidated Financials)

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	3.65	8.90	2.17	-1.69	17.78
Net Cash used in Investing Activities	-13.34	2.13	-15.61	5.86	-11.17
Net Cash flow from Financing Activities	2.58	-3.79	5.43	0.19	-1.34
Net Cash Flow	-7.10	7.24	-8.01	4.35	5.27
Closing Cash & Cash Equivalent	0.06	8.81	2.50	10.52	6.17
Closing Cash & Cash Equivalent Growth (%)	-99.32	252.56	-76.24	70.65	963.14
Total Debt/ CFO (x)	1.44	0.26	2.69	-0.01	0.01

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	3.70	8.82	2.20	-1.45	17.66
Net Cash used in Investing Activities	-13.45	2.14	-17.18	5.82	-11.27
Net Cash flow from Financing Activities	2.26	-3.48	5.41	-0.03	-1.35
Net Cash Flow	-7.49	7.48	-9.57	4.34	5.03
Closing Cash & Cash Equivalent	0.05	10.13	0.67	10.26	5.92
Closing Cash & Cash Equivalent Growth (%)	-99.53	1,416.95	-93.49	73.37	-55.10
Total Debt/ CFO (x)	1.42	0.29	2.65	-0.01	0.01

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	11.04	9.34	11.57	6.73	1.84
Return on Capital Employed (%)	13.63	11.90	15.97	10.07	3.08
Return on Assets (%)	9.18	7.52	9.07	5.16	1.52
Interest Coverage Ratio (x)	64.02	78.01	97.84	139.46	15.82
Asset Turnover Ratio (x)	0.62	0.58	0.73	69.49	70.84
Price to Earnings (x)	10.47	9.00	10.38	10.50	16.03
Price to Book (x)	1.16	0.84	1.20	0.71	0.30
EV/EBITDA (x)	7.79	6.11	6.98	5.42	3.78
EBITDA Margin (%)	21.14	18.76	19.09	12.39	7.29

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	10.35	8.73	10.73	6.18	3.69
Return on Capital Employed (%)	12.81	10.94	14.54	9.24	4.77
Return on Assets (%)	8.70	7.11	8.55	4.83	3.10
Interest Coverage Ratio (x)	59.13	78.27	88.43	110.90	26.46
Asset Turnover Ratio (x)	0.59	0.54	0.71	64.93	65.52
Price to Earnings (x)	10.47	8.97	10.36	10.48	7.28
Price to Book (x)	1.08	0.78	1.11	0.65	0.27
EV/EBITDA (x)	7.80	6.12	6.98	5.43	3.73
EBITDA Margin (%)	21.16	18.80	19.13	12.42	7.46

Financial InsightsAlpa Labs

Income (P&L)
Cash Flow

- Beating 3 Yr Revenue CAGR
  Company's annual revenue growth of 20.82% outperformed its 3 year CAGR of 6.57%. (Source: Consolidated Financials)
- Employee & Interest Expense
  Company has spent less than 1% of its operating revenues towards interest expenses and 12.22% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
- Cash from Operations vs PAT
  Operating cash flow of Rs 3.65 cr is 0.22 times compared to the reported net profit of Rs 16.78 cr. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Alpa Labs Peer Comparison

Alpa Labs Stock Performance
Ratio Performance

CHART
TABLE

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 39.47% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 39.47% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Alpa Labs Stock Performance	2.22	8.65	-0.43	-11.16	41.64	42.55	299.86
SMS Lifesciences Ind Stock Performance	1.69	13.00	32.28	46.44	63.07	32.55	95.75
Brooks Labs Stock Performance	1.47	8.06	-13.83	-24.94	38.08	-12.97	63.82
Bafna Pharma Stock Performance	5.00	0.00	0.00	6.34	0.00	-33.10	907.91
Vaishali Pharma Stock Performance	8.46	17.78	-0.11	16.03	27.47	362.35	693.60
Add More

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 39.47% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 39.47% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Alpa Labs	10.97	1.22	11.04	13.63	9.18	6.57	19.35	15.42	8.01	5.69	0.03	1.44
SMS Lifesciences Ind	28.57	1.34	5.14	8.13	2.32	4.98	6.53	2.06	30.08	1.07	0.55	4.02
Brooks Labs	-11.65	3.48	-29.87	3.56	-21.66	1.03	3.01	1.92	-7.67	1.35	0.08	-0.52
Bafna Pharma	29.53	2.68	9.08	10.29	4.97	29.08	6.32	4.81	3.11	1.75	0.30	2.57
Vaishali Pharma	272.91	4.58	1.67	5.68	0.89	16.51	3.08	0.83	0.67	2.25	0.29	15.63
Add More

Annual Ratios (%)

Choose from Peers

Bal Pharma
Mangalam Drugs
Krebs Biochem
Aarey Drugs
Ind Swift Ltd

Choose from Stocks

See All Parameters

Peers InsightsAlpa Labs

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 39.47% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 39.47% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

Do you find these insights useful?

hate it
meh
love it

Alpa Labs Shareholding Pattern

QOQ Change
Total Shareholdings

Loading...
Showing Alpa Labs Shareholding as on 31 Mar 2024
Category 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Promoters 57.29 57.29 57.29 57.29
Pledge 0.00 0.00 0.00 0.00
FII 0.50 0.95 0.11 0.00
DII 0.00 0.00 0.00 0.00
Mutual Funds 0.00 0.00 0.00 0.00
Others 42.21 41.76 42.60 42.71
Showing Shareholding as on 31 Mar 2024
Category No. of Shares Percentage % Change QoQ
Promoters 1,20,55,010 57.29 % 0.00
Pledge 0 0.00 % 0.00
FII 1,05,426 0.50 % -0.44
Others 88,80,164 42.21 % 0.45

Category	31 Mar 2024	31 Dec 2023	30 Sep 2023	30 Jun 2023
Promoters	57.29	57.29	57.29	57.29
Pledge	0.00	0.00	0.00	0.00
FII	0.50	0.95	0.11	0.00
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	42.21	41.76	42.60	42.71

Category	No. of Shares	Percentage	% Change QoQ
Promoters	1,20,55,010	57.29 %	0.00
Pledge	0	0.00 %	0.00
FII	1,05,426	0.50 %	-0.44
Others	88,80,164	42.21 %	0.45

MF Ownership

MF Ownership details are not available.

Corporate Actions

Alpa Labs Board Meeting/AGM
Alpa Labs Dividends
Others

Meeting Date	Announced on	Purpose	Details
May 28, 2024	May 07, 2024	Board Meeting	Audited Results
Feb 13, 2024	Feb 01, 2024	Board Meeting	Quarterly Results
Nov 07, 2023	Oct 26, 2023	Board Meeting	Quarterly Results
Sep 29, 2023	Sep 20, 2023	AGM	A.G.M.
Aug 14, 2023	Aug 02, 2023	Board Meeting	Quarterly Results

Dividend announcements are not available.
No other corporate actions details are available.

About Alpa Labs

Alpa Laboratories Ltd., incorporated in the year 1988, is a Small Cap company (having a market cap of Rs 181.50 Crore) operating in Pharmaceuticals sector. Alpa Laboratories Ltd. key Products/Revenue Segments include Drugs & Pharmaceuticals, Export Incentives, Other Operating Revenue and Sale of services for the year ending 31-Mar-2023. Show More

Executives
Auditors

MS
Mahendra Singh Chawla
Chairman
PC
Paresh Chawla
Managing Director
SS
Shitul Shah
Whole Time Director
DB
Devendra Baheti
Independent Director
JJ
Jyoti Jain
Independent Director
KD
Krishna Das Malani
Independent Director
PL
Pratibha Lunawat
Independent Director
SB
Sanket Baheti
Independent Director
SC
Sharad Chand Lunawat
Independent Director
SK
Sunil Kumar Valecha
Independent Director
PS
Pravin Shah
Director
VK
Vitthal Kothana
Director
BS
Bakulesh Shah
Chief Financial Officer
SB
Swati Bagh
Co. Secretary & Compl. Officer
Show More
C H Padliya & Co.
Anuradha Ratnaparkhi & Associates

Industry

Pharma - Indian

Key Indices Listed on

Address

33/2, Pigdamber,A.B.Road, Rau,Indore, Madhya Pradesh - 453446

Contact

[email protected]

http://www.alpalabs.in

More Details

FAQs about Alpa Labs share

1. What's Alpa Labs share price today and what are Alpa Labs share returns ?
As on 04 Jul, 2024, 02:08 PM IST Alpa Labs share price was up by 2.22% basis the previous closing price of Rs 87. Alpa Labs share price was Rs 88.17. Return Performance of Alpa Labs Shares:
- 1 Week: Alpa Labs share price moved up by 4.16%
- 1 Month: Alpa Labs share price moved up by 18.19%
- 3 Month: Alpa Labs share price moved down by 6.99%
- 6 Month: Alpa Labs share price moved down by 18.77%
2. How can I quickly analyze Alpa Labs stock?
Key Metrics for Alpa Labs are:
- PE Ratio of Alpa Labs is 10.97
- Price/Sales ratio of Alpa Labs is 1.61
- Price to Book ratio of Alpa Labs is 1.19
3. What are the returns for Alpa Labs share?
Return Performance of Alpa Labs Shares:
- 1 Week: Alpa Labs share price moved up by 4.16%
- 1 Month: Alpa Labs share price moved up by 18.19%
- 3 Month: Alpa Labs share price moved down by 6.99%
- 6 Month: Alpa Labs share price moved down by 18.77%
4. Who owns Alpa Labs?
Promoter and FII owns 57.29, 0.95 shares of Alpa Labs as on 31 Mar 2024
- There is no change in promoter holding from 31 Dec 2023 to 31 Mar 2024
- Foreign Institutional Investors holding have gone down from 0.95 (31 Dec 2023) to 0.5 (31 Mar 2024)
- Other investor holding has gone up from 41.76 (31 Dec 2023) to 42.21 (31 Mar 2024)
5. What's the market capitalization of Alpa Labs?
Within the Pharmaceuticals sector, Alpa Labs stock has a market cap rank of 91. Alpa Labs has a market cap of Rs 187.26 Cr.
6. What is the PE & PB ratio of Alpa Labs?
The PE ratio of Alpa Labs stands at 10.78, while the PB ratio is 1.2.
7. Who's the chairman of Alpa Labs?
Mahendra Singh Chawla is the Chairman of Alpa Labs
8. What are the Alpa Labs quarterly results?
On Consoldiated basis, Alpa Labs reported a total income and loss of Rs 27.57 Cr and Rs 3.55 respectively for quarter ending 2024-03-31. Total Income and profit for the year ending 2024-03-31 was Rs 123.63 Cr and Rs 16.78 Cr.
9. What has been highest price of Alpa Labs share in last 52 weeks?
In last 52 weeks Alpa Labs share had a high price of Rs 115.00 and low price of Rs 68.10
10. What is the CAGR of Alpa Labs?
The CAGR of Alpa Labs is 2.75.
11. Who are peers to compare Alpa Labs share price?
Top 10 Peers for Alpa Labs are Vaishali Pharma Ltd., Bal Pharma Ltd., Bafna Pharmaceuticals Ltd., Mangalam Drugs and Organics Ltd., Krebs Biochemicals & Industries Ltd., Brooks Laboratories Ltd., Aarey Drugs & Pharmaceuticals Ltd., Ind-Swift Ltd., SMS Lifesciences India Ltd. and Biofil Chemicals & Pharmaceuticals Ltd.

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

1 Day	1.75%
1 Week	3.41%
1 Month	17.12%
3 Months	-7.47%
1 Year	25.54%
3 Years	64.3%
5 Years	355.44%

Alpa Labs - Alpa Laboratories Share Price

Alpa Labs - Alpa Labora...

Alpa Labs share price insights

InsightsAlpa Labs

Key Metrics

Key Metrics

Alpa Labs Share Price Returns

ET Stock ScreenersTop Score Companies

Alpa Labs News & Analysis

Alpa Labs Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Alpa Labs Share Recommendations

Alpa Labs Financials

Income (P&L)

Balance Sheet

Cash Flow

Ratios

Insights

Insights

Financial InsightsAlpa Labs

Alpa Labs Peer Comparison

Alpa Labs Stock Performance

Ratio Performance

Insights

Insights

Ratio Performance

Peers InsightsAlpa Labs

Alpa Labs Shareholding Pattern

QOQ Change

Total Shareholdings

MF Ownership

Top Searches:

Corporate Actions

Alpa Labs Board Meeting/AGM

Alpa Labs Dividends

About Alpa Labs

Executives

Auditors

More Details

FAQs about Alpa Labs share

Trending in Markets

Alpa Labs Quick Links

Equity Quick Links

More from Markets